MACROGENICS INC 8-K

What Happened
MacroGenics, Inc. announced on May 11, 2026 (filed May 12, 2026) that it entered into an Asset Purchase Agreement to sell its GMP manufacturing and CDMO operations to Bora Pharmaceuticals Co., Ltd. and Bora Biologics USA, LLC. The buyer will acquire assets and current liabilities tied to MacroGenics’ manufacturing facility at 9704 Medical Center Drive, Rockville, MD and related warehouse operations at 4735 Arcadia Drive, Frederick, MD. The purchaser will pay $122.5 million in cash at closing, subject to customary working capital and indebtedness adjustments, plus up to $5 million of additional post-closing payments tied to manufacturing milestones and certain 2027–2028 professional development services. The transaction has board approval and is expected to close in the third quarter of 2026, subject to customary closing conditions.

Key Details

• Purchase price: $122.5 million cash at closing, subject to customary adjustments.
• Additional consideration: up to $5.0 million in milestone-based post-closing payments and payments for specified services in 2027–2028.
• Assets sold: GMP/CDMO operations (Rockville, MD facility) and related Frederick, MD warehouse; research assets and related operations are excluded.
• Ancillary agreements contemplated at closing: manufacturing & supply agreement, transition services agreement, and a sublease for part of the Rockville facility.

Why It Matters
This transaction converts MacroGenics’ manufacturing assets into immediate cash proceeds, potentially strengthening the company’s balance sheet and funding operations or programs without retaining the CDMO business. At the same time, MacroGenics will rely on the purchaser under a contemplated manufacturing and supply agreement and transition services agreement for future clinical manufacturing needs, which could affect operating flexibility and costs. Investors should note the timing (expected Q3 2026), the cash amount ($122.5M plus up to $5M contingent), and that closing is subject to customary conditions and adjustments.